BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Fathom Holdings
FTHM
$24.5M
| $6.59M | ﹤0.01% |
246,907
+468
| +0.2% | +$13.3K |
|
3777
Root
ROOT
$772M
| $6.57M | ﹤0.01% |
69,219
+16,940
| +32% | +$2.1M |
|
|
SRT
3778
DELISTED
Startek Inc.
SRT
| $6.56M | ﹤0.01% |
1,189,946
-7,263
| -0.6% | -$44.7K |
|
3779
Fresenius Medical Care
FMS
$12.6B
| $6.55M | ﹤0.01% |
187,397
-7,555
| -4% | -$295K |
|
|
LICY
3780
DELISTED
Li-Cycle Holdings Corp.
LICY
| $6.53M | ﹤0.01% |
+69,825
| New | +$5.15M |
|
|
ADAP
3781
DELISTED
Adaptimmune Therapeutics
ADAP
| $6.52M | ﹤0.01% |
1,260,872
+279,478
| +28% | +$1.25M |
|
3782
American Coastal Insurance
ACIC
$461M
| $6.52M | ﹤0.01% |
1,795,385
-1,844,991
| -51% | -$7.41M |
|
3783
TIM SA
TIMB
$8.27B
| $6.49M | ﹤0.01% |
603,875
+20,010
| +3% | +$225K |
|
|
SSAAU
3784
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
| $6.43M | ﹤0.01% |
645,908
-4,092
| -0.6% | -$40.7K |
|
|
PPTA
3785
Perpetua Resources
PPTA
$3.1B
| $6.4M | ﹤0.01% |
1,285,882
+18,321
| +1% | +$102K |
|
3786
PDS Biotechnology
PDSB
$13M
| $6.4M | ﹤0.01% |
429,178
+27,756
| +7% | +$346K |
|
|
LGF.A
3787
CALL
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $6.39M | ﹤0.01% |
450,000
-283,300
| -39% | -$4.14M |
|
3788
Werewolf Therapeutics
HOWL
$18.8M
| $6.35M | ﹤0.01% |
369,961
+4,098
| +1% | +$69.9K |
|
|
POSH
3789
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $6.34M | ﹤0.01% |
266,647
+25,216
| +10% | +$808K |
|
|
TERN
3790
DELISTED
Terns Pharmaceuticals
TERN
| $6.28M | ﹤0.01% |
602,556
+164,952
| +38% | +$1.71M |
|
|
HOOK
3791
DELISTED
HOOKIPA Pharma
HOOK
| $6.2M | ﹤0.01% |
105,351
+299
| +0.3% | +$21.7K |
|
|
MRUS
3792
DELISTED
Merus
MRUS
| $6.14M | ﹤0.01% |
279,316
+27,740
| +11% | +$595K |
|
3793
ThredUp
TDUP
$416M
| $6.14M | ﹤0.01% |
282,908
+25,428
| +10% | +$572K |
|
|
IMA
3794
ImageneBio Inc
IMA
$66.6M
| $6.11M | ﹤0.01% |
40,328
+2,850
| +8% | +$414K |
|
3795
LSI Industries
LYTS
$912M
| $6.1M | ﹤0.01% |
787,542
+1,052
| +0.1% | +$8.02K |
|
3796
Cineverse
CNVS
$68.2M
| $6.06M | ﹤0.01% |
120,766
+23,012
| +24% | +$811K |
|
3797
Sasol
SSL
$7.17B
| $6.04M | ﹤0.01% |
320,370
+5,011
| +2% | +$76.5K |
|
3798
Vanguard Total World Stock ETF
VT
$81.9B
| $6.02M | ﹤0.01% |
59,088
+48,403
| +453% | +$5.07M |
|
3799
Summit Therapeutics
SMMT
$11.2B
| $6.01M | ﹤0.01% |
1,200,590
+105,443
| +10% | +$757K |
|
|
KLDO
3800
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $5.99M | ﹤0.01% |
1,096,828
+21,806
| +2% | +$135K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.